PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Hospitals and diagnostic centers – Market size and forecast 2017-2022 • Research laboratories – Market size and forecast 2017-2022 • Others – Market size and forecast 2017-2022 • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Growing importance of promotional activities • Increasing cases of cancer • Emergence of new disease targets PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abcam • BD • bioMérieux • Bio-Rad Laboratories • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations   Exhibit 01: Parent market Exhibit 02: Global immunoassay market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition – Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global ELISA testing market 2017-2022 ($ mn) Exhibit 09: Global – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition – Five forces 2017 Exhibit 18: Customer landscape Exhibit 19: End-user – Market share 2017-2022 (%) Exhibit 20: Comparison by end-user Exhibit 21: Hospitals and diagnostic centers – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Hospitals and diagnostic centers – Year-over-year growth 2018-2022 (%) Exhibit 23: Research laboratories – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Research laboratories – Year-over-year growth 2018-2022 (%) Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn) Exhibit 26: Others – Year-over-year growth 2018-2022 (%) Exhibit 27: Market opportunity by end-user Exhibit 28: Global – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Advantages of disease diagnosis Exhibit 41: Barriers for the diagnostics market in developing countries Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Abcam overview Exhibit 48: Abcam – Business segments Exhibit 49: Abcam – Organizational developments Exhibit 50: Abcam – Geographic focus Exhibit 51: Abcam – Segment focus Exhibit 52: Abcam – Key offerings Exhibit 53: BD overview Exhibit 54: BD – Business segments Exhibit 55: BD – Organizational developments Exhibit 56: BD – Geographic focus Exhibit 57: BD – Segment focus Exhibit 58: BD – Key offerings Exhibit 59: bioMérieux overview Exhibit 60: bioMérieux – Business segments Exhibit 61: bioMérieux – Organizational developments Exhibit 62: bioMérieux – Geographic focus Exhibit 63: bioMérieux – Segment focus Exhibit 64: bioMérieux – Key offerings Exhibit 65: Bio-Rad Laboratories overview Exhibit 66: Bio-Rad Laboratories – Business segments Exhibit 67: Bio-Rad Laboratories – Organizational developments Exhibit 68: Bio-Rad Laboratories – Geographic focus Exhibit 69: Bio-Rad Laboratories – Segment focus Exhibit 70: Bio-Rad Laboratories – Key offerings Exhibit 71: Thermo Fisher Scientific overview Exhibit 72: Thermo Fisher Scientific – Business segments Exhibit 73: Thermo Fisher Scientific – Organizational developments Exhibit 74: Thermo Fisher Scientific – Geographic focus Exhibit 75: Thermo Fisher Scientific – Segment focus Exhibit 76: Thermo Fisher Scientific – Key offerings

Abcam BD bioMérieux Bio-Rad Laboratories Thermo Fisher Scientifi